spacer
home > pmps > winter 2019 > from governance to provenance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

From Governance to Provenance

Imagine a world where all medical supplies can be traced back to their original source: a world where one can find out exactly where they were manufactured, packaged, and delivered. Picture being able to see its journey through the supply chain: whenever it had been touched, the temperature it was kept at, and whether it was damaged in transit. Just imagine if the item became infected with an airborne disease and the retailer it was purchased from could contact the enduser directly to recall the product and prevent consumption. In an era where the consumer appetite to understand the provenance of products has reached fever pitch, this futuristic utopia sounds as expensive as it does implausible, except it is not – it is well within reach. The ability to deliver it using affordable track and trace technology promises to transform the supply chain not only for medicines, devices, and pharmaceuticals, but also for perishable food and groceries and just about everything else. Welcome to so-called tomorrow’s world, where many of these benefits are achievable today. It is time to deliver them.

Chain Reaction

The supply chain is evolving. Traditionally, the function has focussed on answering two basic questions: ‘where is my product?’ and ‘when is it going to arrive?’ However, this narrow focus has typically been blighted by information black holes where answering these questions is impossible. This lack of visibility has driven huge operational inefficiencies that manifest themselves in excess inventory, extended lead times, and excessive costs for expedited forms of transportation. Blind spots in the supply chain can also lead to other nasty surprises, such as the product arriving either incorrect or substandard because it has not been effectively monitored or managed throughout its journey. These failings have a damaging impact on profitability, customer experience, and long-term brand loyalty.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Chris Sultemeier brings over 30 years of leadership experience in supply chain operations to rfxcel. Chris was the Executive Vice President of Logistics at Walmart, as well as the President and CEO of Walmart Transportation. During his tenure, he was responsible for all domestic and global distribution and fulfilment. Chris received the prestigious Sam M Walton Entrepreneur of the Year Award for his efforts on sustainability. He also serves as an instructor at the Massachusetts Institute of Technology’s Master’s Degree programme for supply chain/logistics/ transportation, US.
spacer
Chris Sultemeier
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Innovative Micro-Infusion Pump for Gerresheimer Subsidiary Sensile Medical Developed and Successfully Launched for EVER Pharma

Düsseldorf/Olten, July 03, 2019 – Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine®, this wearable microinfusion pump recently received European CE certification and has already been launched in several European countries. The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical to be available on the market, it gives Parkinson’s patients greater independence in their day-today lives.
More info >>

White Papers

Generating Scientific Insights by Deep Collaboration - Bridging the Big Data Divide Between Clinical and Research

BioFortis

Translational research, biomarker discovery, clinical studies and even biobanking have become increasingly data intensive.  However, generating scientific insights from such disparate “big” data sources across multiple domains is a challenge for both researchers and the informaticians that support them. Download our Deep Collaboration Whitepaper and and learn how to bridge the clinical and research divide to better explore your biomarker based trials.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement